ID-5184 Wonca Abstracts supplement A-K 13-10-23 - Flipbook - Page 243
WONCA 2023 Supplement 1: WONCA 2023 abstracts (A–K)
A
B
C
D
Online evaluation of psychological and neuropsychological
deficits associated with long COVID
Dr Raquel Gómez Bravo1,2, Charles Benoy1,2, Mark Ritzen2, Alexandre Infanti1, Joel Billieux1,
Claus Vögele1
1
University of Luxembourg, 2CHNP (Rehaklinik)
E
F
G
H
I
J
K
Background
It is estimated that between 10% and 20% of people who experienced COVID-19 develop a
‘post-COVID-19 condition’ or ‘long COVID’ (LC), which includes all mid- and long-term physical,
psychological and neuropsychological symptoms.
Question
What are the psychological and neuropsychological symptoms associated with long COVID?
Methods
Descriptive, online cross-sectional questionnaire and neuropsychological tests. Participants were
recruited through public relations, information and social media campaigns, targeting long COVID
patients, general public and healthcare professionals.
Outcomes
Out of the 1895 participants who completed the survey, 78.4% reported to have had COVID-19, and
64.3% experienced LC symptoms with fatigue as the most frequently reported symptom (65.4%). The
estimated most common coronavirus variant was omicron (40%), followed by delta (11.5%). There were
positive and statistically significant correlations between reported physical symptoms and results from
the neuropsychological tests, perceived stress, anxiety and depression scores. The average time that
elapsed between LC symptom onset and completion of the online survey was 8.3 months.
Conclusion
Online real-time neuropsychological testing should be considered as part of the routine evaluation of
long COVID patients to specifically treat these symptoms within multidisciplinary teams.
Discussion
Validated self-report assessment scales and neuropsychological tests should be included in standard
diagnostic procedures to adequately address neuropsychological and mental health consequences of
long COVID.
Take home message for practice
eHealth solutions offer a valuable alternative to provide effective assessment for long COVID patients
experiencing cognitive impairment.
241